Best ideas portfolio, trading on the ASX
Based on our team’s deep research, this portfolio offers our best investment ideas in Global SMIDs as an active ETF quoted on the ASX.
Focus on targeted return
Built on investments we have identified with the ability, in our view, to generate attractive returns over the longer-term.
We trade time for value
Exploits short-term volatility and poor short-term price discovery due to the fund’s longer time horizon.
SMID cap expertise
Managed by a global team with deep research expertise and strong capital allocation track record.
The Fund aims to outperform the MSCI ACWI SMID Cap Index (after fees and expenses and before taxes) on a rolling five-year basis.
The Vaughan Nelson Global SMID Cap Equity team seek investments that in our view have the ability to generate attractive returns over the longer-term.
Stock selection is driven by this targeted return objective, not benchmark construction.
The investment team have a rigorous, bottom-up fundamental analysis and disciplined approach to help uncover drivers of long-term strong performance.
3 lenses for success
Undervalued earnings growth
Where the future redeployment of capital is not reflected in current valuation
Where the asset is priced at a significant discount or we identify a catalyst to close the valuation gap.
Undervalued dividend yield
Where the majority of targeted return is generated by the dividend.
The Vaughan Nelson Global Equity SMID Fund (Quoted)
|James Eisenman, CFA, CPA
Marco Priani, CFA, CPA, FRM
Kevin Ross, CFA
Chris Wallis, CFA, CPA Find out more
|MSCI ACWI SMID Cap Index
|1 June 2022
|657 058 841
(the constitution for the Fund permits a performance fee to be charged. However the RE has waived its right to charge this fee)
|1.12% per annum (inclusive of the net effect of GST)
Research and ratings
Contact your State representative for a copy of the report.
The rating contained in this document is issued by SQM Research Pty Ltd ABN 93 122 592 036 AFSL 421913. SQM Research is an investment research firm that undertakes research on investment products exclusively for its wholesale clients, utilising a proprietary review and star rating system. The SQM Research star rating system is of a general nature and does not take into account the particular circumstances or needs of any specific person. The rating may be subject to change at any time. Only licensed financial advisers may use the SQM Research star rating system in determining whether an investment is appropriate to a person’s particular circumstances or needs. You should read the product disclosure statement and consult a licensed financial adviser before making an investment decision in relation to this investment product. SQM Research receives a fee from the Fund Manager for the research and rating of the managed investment scheme.
Download a copy of the Independent Investment Research report.
The Independent Investment Research research rating requires to be read with the full research report that can be found on the issuers website (or upon request) together with our full disclaimer that is found on the front cover of our research note. We require readers of our research note to obtain advice from their wealth manager before making any decisions with respect to the recommendation on this note. The note is not general advice just financial information without having regard too the financial circumstances of the reader.
The Zenith Investment Partners (ABN 27 103 132 672, AFS Licence 226872) (“Zenith”) rating (IML1199AU & ASX:VNGS assigned September 2023) referred to in this piece is limited to “General Advice” (s766B Corporations Act 2001) for Wholesale clients only. This advice has been prepared without taking into account the objectives, financial situation or needs of any individual, including target markets of financial products, where applicable, and is subject to change at any time without prior notice. It is not a specific recommendation to purchase, sell or hold the relevant product(s). Investors should seek independent financial advice before making an investment decision and should consider the appropriateness of this advice in light of their own objectives, financial situation and needs. Investors should obtain a copy of, and consider the PDS or offer document before making any decision and refer to the full Zenith Product Assessment available on the Zenith website. Past performance is not an indication of future performance. Zenith usually charges the product issuer, fund manager or related party to conduct Product Assessments. Full details regarding Zenith’s methodology, ratings definitions and regulatory compliance are available on our Product Assessments and at Fund Research Regulatory Guidelines